Hepatocellular carcinoma (HCC) is a morbid condition for which surgical and ablative
therapy are the only options for cure. Nonetheless, over half of patients treated with an R0 …

In 2010, a panel of Chinese pathologists reported the first expert consensus for the
pathological diagnosis of primary liver cancers to address the many contradictions and …

Background: Primary liver cancer, around 90% are hepatocellular carcinoma in China, is the
fourth most common malignancy and the second leading cause of tumor-related death …

Background & Aims Microvascular invasion (MVI) impairs surgical outcomes in patients with
hepatocellular carcinoma (HCC). As there is no single highly reliable factor to preoperatively …

Background: Primary liver cancer, of which around 75–85% is hepatocellular carcinoma in
China, is the fourth most common malignancy and the second leading cause of tumor …

Abstract Background: Hepatocellular carcinoma (HCC)(about 85–90% of primary liver
cancer) is particularly prevalent in China because of the high prevalence of chronic hepatitis …

Standard for diagnosis and treatment of primary liver cancer (2022 edition) 中文|English ISSN
1001-5256 (Print) ISSN 2097-3497 (Online) CN 22-1108/R Home About Journal 1.Journal …

Objectives To develop radiomics-based nomograms for preoperative microvascular invasion
(MVI) and recurrence-free survival (RFS) prediction in patients with solitary hepatocellular …

PURPOSE To report the efficacy and safety of postoperative adjuvant hepatic arterial
infusion chemotherapy (HAIC) with 5-fluorouracil and oxaliplatin (FOLFOX) in hepatocellular …

Objective: We compared surgical resection (SR) and radiofrequency ablation (RFA) as first-
line treatment in patients with hepatocellular carcinoma (HCC) based on the risk of …